Nuveen’s Aurinia Pharmaceuticals AUPH Stock Holding History

Nuveen’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.68M	Sell	653,424 -11,893	-2%	-$174K	﹤0.01%	1574
2025 Q4	$10.6M	Buy	665,317 +360,084	+118%	+$5.1M	﹤0.01%	1522
2025 Q3	$3.37M	Buy	305,233 +39,272	+15%	+$429K	﹤0.01%	2096
2025 Q2	$2.25M	Sell	265,961 -979,588	-79%	-$7.85M	﹤0.01%	2251
2025 Q1	$10M	Sell	1,245,549 -246,752	-17%	-$2M	﹤0.01%	1554
2024 Q4	$13.4M	Buy	1,492,301 +138,054	+10%	+$1.13M	﹤0.01%	1437
2024 Q3	$9.93M	Sell	1,354,247 -449,183	-25%	-$2.79M	﹤0.01%	1614
2024 Q2	$10.3M	Sell	1,803,430 -255,677	-12%	-$1.35M	﹤0.01%	1563
2024 Q1	$10.3M	Sell	2,059,107 -293,018	-12%	-$1.99M	﹤0.01%	1566
2023 Q4	$21.1M	Sell	2,352,125 -338	-0%	-$2.78K	0.01%	1123
2023 Q3	$18.3M	Buy	+2,352,463	New	+$23M	0.01%	1094

Other funds holding AUPH

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return